Panel Discussion: Considering Digital Pathology & AI/ML from a Drug Development Pipeline Perspective
Time: 1:25 pm
day: Day Three Track A
Details:
- What are the greatest barriers to routine digital pathology clinical use? What approaches can we take to overcome them?
- Translational studies – leveraging digital pathology to describe populations
- Leveraging digital pathology to define clinical endpoints
